About Medplan Private Limited
Data last updated:
Medplan Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33309DL2020PTC366472. Its GSTIN is 09AANCM5935G1Z1 (Uttar Pradesh).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹70 Lakh. It is led by directors Sarbjit Singh and Puneet Manocha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 115 Naraina Industrial Area Phase – I, Delhi, India – 110028.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.13 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹37.76 Lakh (net margin 12.1%) and EBITDA of ₹85.98 Lakh (EBITDA margin 27.5%).
As per MCA filings, the company has open charges of ₹2.78 Cr on record.
For more details, the company can be reached via its website medplan.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressC – 115 Naraina Industrial Area Phase – I, Delhi, India – 110028
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medplan Private Limited
The main business activity of Medplan is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medplan Private Limited FY 2025 filings available
Medplan Private Limited reported revenue of ₹3.13 Cr (up 313% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Medplan Private Limited
Revenue rose 313% in the latest year. EBITDA rose 418% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Medplan Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹85.98 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹37.76 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Medplan Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 27.5% | •••• | •••• | •••• |
| Net Profit Margin | 12.1% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medplan are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medplan Private Limited
Medplan Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Medical Consumables). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Siddhi Cool Tech Private Limited | ₹3.22 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Ahmedabad, Gujarat, India |
| Human Biosciences India Limited | ₹3.21 Cr (FY 2025) | •••• | •••• | -30.0% | •••• | Delhi, India |
| Quicksupply (OPC) Private Limited | ₹3.21 Cr (FY 2021) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Hanscure Lifescience Private Limited | ₹3.21 Cr (FY 2025) | •••• | •••• | 82.0% | •••• | Surat, Gujarat, India |
| Vimek Bioconcept Private Limited | ₹3.18 Cr (FY 2024) | •••• | •••• | -24.0% | •••• | Mumbai, Maharashtra, India |
| Medplan Private Limited this company | ₹3.13 Cr (FY 2024) | •••• | •••• | 313.0% | •••• | Delhi, India |
| Mediklin Healthcare Limited | ₹3.09 Cr (FY 2024) | •••• | •••• | 0.0% | •••• | Mumbai, Maharashtra, India |
| Arham Scientific Products Private Limited | ₹3.08 Cr (FY 2025) | •••• | •••• | 161.0% | •••• | Delhi, India |
| Renaud Bio Private Limited | ₹3.07 Cr (FY 2025) | •••• | •••• | 14.0% | •••• | Patancheru, Telangana, India |
| Softouch Hygiene Products Limited | ₹3.07 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Ahmedabad, Gujarat, India |
| Bonne Care Private Limited | ₹3.05 Cr (FY 2020) | •••• | •••• | -43.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Medplan by revenue in the Healthcare industry (Medical Consumables), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Medplan Private Limited
Medplan Private Limited is audited by GREESHCHANDRAGUPTA for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GREESHCHANDRAGUPTA | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Medplan Private Limited
Medplan has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarbjit Singh Also directs: Psa Healthcare Private Limited, MHL Healthcare Limited, Sangat Printers Private Limited and 1 more | Director | 19 Jul 2020 | 6 Years 2 Months | Current |
| Puneet Manocha Also directs: Psa Healthcare Private Limited, MHL Healthcare Limited, Medplan Exports LLP and 3 more | Director | 19 Jul 2020 | 6 Years 2 Months | Current |
Ownership and Shareholding of Medplan Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medplan Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Dec 2021 | Others | ₹79.27 Lakh | Open |
| 17 Nov 2020 | Others | ₹1.99 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Medplan Private Limited
Medplan Private Limited has a workforce of 0 employees as of Mar 22, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Medplan Private Limited
Medplan Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Puneet Manocha was appointed as Director on 19 Jul 2020.
Credit Ratings, Litigation & Regulatory Alerts for Medplan Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medplan Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medplan Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medplan Private Limited
Medplan has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AANCM5935G1Z1 | Uttar Pradesh | Active | 25 Aug 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medplan Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medplan Private Limited
Medplan is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 July 2020 (6+ years old) and is registered under CIN U33309DL2020PTC366472.
Medplan reported revenue of ₹3.13 Cr for FY 2024 (up 313% YoY).
Medplan has 2 current directors:
- Sarbjit Singh - Director
- Puneet Manocha - Director
Medplan reported a net profit of ₹37.76 Lakh (net margin 12.1%) and EBITDA of ₹85.98 Lakh (EBITDA margin 27.5%) for FY 2024, as per its filed financial statements.
The GSTIN of Medplan is 09AANCM5935G1Z1, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Medplan is U33309DL2020PTC366472. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medplan was incorporated on 19 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medplan by revenue are Siddhi Cool Tech Private Limited, Human Biosciences India Limited, Quicksupply (OPC) Private Limited, Hanscure Lifescience Private Limited, Vimek Bioconcept Private Limited and 5 more, all in the Healthcare industry (Medical Consumables).
Puneet Manocha was appointed as Director on 19 Jul 2020. Sarbjit Singh was appointed as Director on 19 Jul 2020.
Medplan can be reached through the website medplan.in. Its registered office is in Delhi, India.
The registered office of Medplan is at C – 115 Naraina Industrial Area Phase – I, Delhi, India – 110028.